Back to News
Market Impact: 0.2
Notable ETF Outflow Detected - XBI, TWST, BIIB, HALO
Source: Nasdaq
Healthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
State Street's SPDR S&P Biotech ETF (XBI) recorded an estimated $320.6 million weekly outflow, reducing shares outstanding by 3.1%. The redemption signals modestly negative investor positioning toward the biotech sector, though the report provides no company-specific fundamental catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
More News
- The secret signs the bond sell-off might be ending
- State Street Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- Traders Waver on Fed Hike Bets After Jobs Report
- The next weak link in Europe’s bond market? UBS has a new short position
- Trump vs Europe as US presses for release of emergency diesel stocks
- US Stocks Rise Despite Soft Jobs Report
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Best AI Stock Research Tools for Professional Investors
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More